University of Vermont,University of Vermont Board of Trustees Chair Robert F. Cioffi today announced the appointment of Dr. A. John Bramley as Interim President, effective August 1. Bramley, a longstanding member of the UVM faculty, has served as Department Chair of Animal Sciences, Dean of the College of Agriculture and Life Sciences, and Provost and Senior Vice President of the University. In 2006 he also served as Acting President during President Daniel Mark Fogel’s illness. From 2007 to 2011 he was President and CEO of the Windham Foundation, the largest private foundation registered in Vermont. In recognition and honor of his service, the Windham Foundation announced last week the creation of the A. John Bramley Lecture Series, designed to focus on preserving Vermont’s rural communities.”We are extremely fortunate that John Bramley was both available and willing to step into this important role,” Cioffi said. “Quite frankly, there could not be a better choice for this job in light of John’s experience, skills, character, and knowledge of UVM, in addition to his outstanding scholarly record. One of the Board’s primary goals is to keep the University’s upward trajectory moving ahead, and the appointment of John Bramley ensures that is going to happen.””Dan Fogel is leaving us with an impressive legacy of accomplishment and a strong foundation for further success. Even though he will be in this role for a relatively short time, John is not going to be a ‘caretaker,’ and will be pushing our key initiatives forward. I couldn’t be more pleased that John has agreed to take on the responsibilities of Interim President, and I know that he will be welcomed back to UVM with open arms,” Cioffi remarked.Bramley is expected to serve as Interim President until July 2012, and will not be a candidate for the position of President, for which a search is underway.In accepting the position, Bramley said, “I love UVM and have devoted a large part of my life to it. After leaving Windham I had planned to be doing other things, but I concluded they should be put on hold if I could help the institution at this critical point. I am grateful for and humbled by the confidence the Board has placed in me, and I will do my best to see to it that the University continues to gain ground. I very much appreciate all that President Fogel has done to put this institution in a strong, viable position and I have every intention to work with the University community and beyond to make us even better.””I look forward to re-engaging with the community, reuniting with old friends and colleagues, and getting to know new ones, beginning August 1st. You will hear more from me after that date. Until then, President Fogel will continue to provide effective leadership for UVM,” Bramley stated.Bramley was born and educated in the United Kingdom. He graduated with first class honors B.Sc. in Microbiology from the University of Newcastle upon Tyne in 1971 and completed his Ph.D. in Veterinary Microbiology at the University of Reading in 1975. Biography of A. John Bramley B.Sc., Ph.D., D.Sc.John Bramley was born and educated in the United Kingdom. He graduated with first class honors B.Sc. in Microbiology from the University of Newcastle upon Tyne in 1971 and completed his Ph.D. in Veterinary Microbiology at the University of Reading in 1975.Between 1975 and 1985 he was a research scientist at the National Institute for Research in Dairying, Shinfield, UK, becoming an internationally-recognized authority on bovine mastitis. He was the recipient of the George Fleming Award of the British Veterinary Journal and twice was a recipient of the Peter Bridge Award of the British Cattle Veterinary Association. In 1985, he moved to the Institute for Animal Health in Compton, UK, where he led a large multi-disciplinary research group and the Division of Environmental Science. During this period he also studied with colleagues at the University of Florida in Gainesville and at the University of Southern Chile.In 1990, he became Chair of the Department of Animal Sciences at the University of Vermont and in 1999 was appointed Dean of the College of Agriculture & Life Sciences and Director of the Vermont Agricultural Experiment Station. From 2001 to 2006 he was the Provost and Senior Vice President.of the University, working with Presidents Colodny and Fogel, During the illness of President Fogel in 2006 he served as Acting President.. From 2007 to 2011 he was President and CEO of the Windham Foundation, the largest private foundation registered in Vermont which owns and operates the Old Tavern at Grafton and the Grafton Village Cheese Company. His research focused on bovine mastitis and he led a team of UVM researchers in cloning a gene that has led to the world’s first mastitis-resistant animals. He is the author of some 150 research papers, review articles, and book chapters. He held the rank of professor in Animal Sciences and in Microbiology and Molecular Genetics and was awarded emeritus status in 2008. Dr. Bramley was honored by the Green Mountain Council Boy Scouts of America as their Distinguished Citizen of the Year. He was an inaugural inductee of the Vermont Agricultural Hall of Fame and is a member of the Vermont Academy of Sciences. In July, 2011 the Windham Foundation announced the creation of the A. John Bramley Lecture Series, designed to focus on preserving Vermont’s rural communities.
Photo by Joe FoleyROAD CYCLINGAthens Twilight Criteriumathens, georgiaAPRIL 26-27, 2013Founded in 1980, the Athens Twilight was the first nighttime cycling race in the U.S. in more than 60 years. The race saw 40 riders that first year. It’s now the premier crit in the country, with eight separate race classes and 150 fast sprint cyclists. The course is a simple 1K rectangle through downtown Athens, lined with 30,000 fans cheering, drinking, and even heckling. Spectators are really close to the action. Cyclists are going 35 mph, right in front of you, and you get a sense for just how fast that is. It’s the fastest race they’ll ride all year. It’s also a rough and tumble sport. You’ve got 100 bike riders, inches apart, pushing each other. It’s like a NASCAR event. athenstwilight.comWintergreen Ascentroseland, virginiaAPRIL, 2013This classic hill climb begins at Devils Backbone Brewing Company and follows Hwy 664 as it ascends Wintergreen Mountain. There is no down. Only up. Here’s a number’s breakdown of this short, but tough race.6.75 miles—Distance up the mountain30 seconds—Intervals that riders are sent up the mountain in classic time-trial fashion. Pedal your heart out to catch the rider in front of you and stay ahead of the rider behind you.7.4 percent—Average grade incline from start to finish15 percent—Max grade during the course2,626 feet—Total elevation you’ll gainvacycling.orgAssault On Mount Mitchellspartanburg, south carolinaMAY 20, 2013The Assault may not be the toughest road race in the South, but it’s easily the most iconic. Is there any challenge more primal than trying to ride up the biggest mountain around? From 100 miles away? 750 riders accept this challenge every year, pedaling 102 miles from Spartanburg, S.C. to the top of Mount Mitchell, a route that takes in 10,350 feet of elevation gain. The first 75 miles are rolling, but the last 25 miles are packed with the most brutal climbs. freewheelers.infoJeremiah Bishop’s Alpine Loop Gran Fondoharrisonburg, virginiaSEPTEMBER 29, 2013It’s billed as the toughest gran fondo in America, 104 miles of Virginia and West Virginia back roads with 11,000 feet of climbing and two gravel roads. “I’ve been training on the route for almost a decade. It’s a ball buster, for sure. It’s one of the hardest training rides I’ll do,” says founder Jeremiah Bishop. “It’ll find the limit of most people, but still allow them to enjoy a beer afterwards. Start in the city of Harrisonburg, then ride through the agricultural bread basket of Virginia and into the national forest in West Virginia. Sheep cling to the sides of the mountains, there are open meadows on peaks…it’s like riding in Switzerland. “It harkens back to an era when people who rode road bikes weren’t soft men who shaved their legs and rode $10,000 bikes,” continues Bishop. “Road cycling used to be hard core. This gets back to the soul of the ride.” alpineloopgranfondo.comSix Gap Centuryhelen, georgiaSEPTEMBER 29, 2013Some say it’s the toughest century in the South. Show up and you’ll pedal the steepest mountain gaps in Georgia, following the same route that pros battled on during the Tour de Georgia. In the middle of the ride, there’s a time-trial race up Hogpen Gap, the toughest climb on the route. The winner is proclaimed King of the Mountain. “Everyone’s mellow at the beginning, but then you have this independent race up the gap where everyone has a chip and digs deep because your time is compared to everyone else’s,”says Brian Toone, last year’s king. “You’re spent at the end of the KOM challenge, but you’ve got half the century left to ride.” cyclenorthgeorgia.comBest of the RestRoanoke Twilight CriteriumRoanoke, VirginaApril, 2013 • roanoketwilight.com3 State 3 Mountain ChallengeChattanooga, TennesseeMay 4, 2013 • chattbike.comBlack and Blue Double CenturyBoone, North CarolinaJune 8, 2013 • blackandbluerelay.comBlood, Sweat, and GearsBoone, North CarolinaJune, 2013 • bloodsweatandgears.orgTour of Page CountyLuray, VirginaApril 26-28, 2013 • pagevalleycycling.comBike Virginia TourBuena Vista, VirginiaJune 21-26, 2013 • bikevirginia.orgHot Dogget 100Mars Hill, North CarolinaJuly 13, 2013 • hotdoggett100.org24 Hours of BootyCharlotte, North CarolinaJuly 26-27, 2013 • 24hoursofbooty.orgTour de Burg (road days)Harrisonburg, VirginiaJuly, 2013 • svbcoalition.orgBlue Ridge BreakawayWaynesville, North CarolinaAugust 17, 2013 • blueridgebreakaway.comShenandoah Valley CenturyHarrisonburg, VirginiaSeptember, 2013 • svbcoalition.orgTown Mountain Hill ClimbAsheville, North CarolinaSeptember, 2013 • ashevillewomenscycling.comGeorge Hincapie Gran FondoGreenville, South CarolinaOctober, 2013 • granfondohincapie.comFinal Fifty RideGreenville, South CarolinaDecember 29, 2013 • greenvillespinners.orgFor more great Race Ahead information check out these sections:SnowsportsTrail RunningRoad RunningMountain BikingRoad CyclingClimbingPaddlingHikingMultisportSuperlatives
“Starting today, October 24th, we’re making influenza shots available to everyone,” said Health and Human Services Secretary Mike Leavitt. “There’s no reason for anyone to delay or go without their seasonal flu shot.” Von Eschenbach announced that the FDA is forming a “rapid response team” of experts to help make sure antiviral drugs are available in the event of a flu pandemic. In early September, the Centers for Disease Control and Prevention (CDC) had recommended that flu shots be reserved for people at risk for serious flu complications until today. (The recommendation did not apply to MedImmune’s live-virus vaccine [FluMist], which is licensed only for healthy people between ages 5 and 49.) Despite some scattered shortages caused by delayed vaccine deliveries, the CDC stuck to that timetable. See also: “Providers in areas with sufficient flu vaccine already should open up their programs to the expanded group of people” not at high risk for complications, she said. She recommended that clinicians who have an ample supply of vaccine inform local public health officers so the latter can help shift surplus doses to providers who need them. CDC officials repeated their estimate that at least 71 million doses of flu vaccine will be available in the United States this season, compared with about 60 million last year, when the loss of 48 million doses expected from Chiron triggered shortages. CDC Director Dr. Julie Gerberding said the flu season is just beginning. “We’re seeing very sporadic activity in seven states, and local activity in one state.” Leavitt observed that oseltamivir has been “much in the news” because of the chance that H5N1 avian flu will lead to a human flu pandemic. Many countries, including the United States, are trying to build stockpiles of oseltamivir, but the drug takes a long time to produce. Some localized vaccine shortages have been reported as a result of delayed deliveries, but they are expected to clear up soon, Gerberding said. At a news briefing, officials also warned that the threat of a flu pandemic may spur the sale of fake versions of the antiviral drug oseltamivir (Tamiflu). To make sure they get the genuine article, officials said, people should seek the drug through their physician. The best way to avoid fake oseltamivir is to get it from state-licensed pharmacies, said von Eschenbach. “We feel strongly that the best protection for patients is to avail themselves of the drug in the context of a doctor-patient relationship.” He added that people seeking a flu shot should make an appointment, because some providers may not have received their vaccine yet. In a news release issued this afternoon, he said, “Using the Rapid Response Team approach, we believe we could review a complete drug application in six to eight weeks.” Because demand for the drug far exceeds the supply, said Leavitt, “We’re concerned about the threat of counterfeiting of Tamiflu.” The CDC still expects 60 million doses from Sanofi Pasteur, 3 million from MedImmune, and 8 million from GlaxoSmithKline, said CDC spokeswoman Christina Pearson. She said the agency also expects up to 18 million doses from Chiron, which until last week was projecting 18 million to 26 million. Gerberding said that right now she does not expect a shortage of oseltamivir for use against seasonal flu. “The manufacturer still has several million doses in the pipeline,” she said. “The doses that haven’t been distributed yet exceed the number prescribed last year by a significant amount. At this point there’s no evidence of a shortage that’s going to result in any clinical impact on patients. We’ll monitor that.” Oct 24, 2005 (CIDRAP News) Seasonal influenza shots are not just for high-risk groups anymore, and everyone interested in a shot should go ahead and seek one out, federal health officials said today. Gerberding said people who experience flu symptoms and have not been vaccinated, especially if they are in a high-risk group, should call their physician promptly to find out if treatment with an antiviral drug would be appropriate. Preventive treatment with an antiviral may be indicated n some cases, such as for people who can’t be vaccinated because of an egg allergy. In response to questions, Leavitt and Andrew von Eschenbach, acting commissioner of the Food and Drug Administration (FDA), said they had seen no evidence of counterfeiting to date. But Leavitt said, “It’s a situation that’s ripe for counterfeiting. The WHO [World Health Organization] now indicates that counterfeit drug making is a $34 billiona-year industry. We’re seeing it in many other instances.” FDA news releasehttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108502.htm